Advertisement
Interviews
View More
Improving Symptom Detection and Early Intervention in Aortic Stenosis

An expert highlights the need for early detection of aortic stenosis symptoms in elderly patients, urging pharmacists and clinicians to monitor subtle changes.

Barriers and Opportunities for Digital Wearables in Heart Failure Management

Biykem Bozkurt, MD, PhD, FACC highlights the need for reliable activity monitoring in heart failure care, addressing challenges of digital wearables in clinical practice.

Integrating Pharmacists into Early CKM Detection and Holistic Care Pathways

Pharmacists play a crucial role in holistic healthcare, enhancing patient care through education and collaboration with allied health professionals.

Understanding Second Primary Tumors in C-POST: Definitions, Incidence, and Clinical Implications of Cemiplimab

Danny Rischin, MD, reviews findings from the C-POST trial.

Managing Safety and Supportive Care With Pluvicto: Insights From the PSMAddition Trial

Scott Tagawa, MD, professor of medicine and urology at Weill Cornell Medicine, discusses safety and tolerability findings observed to date, renal and hematologic considerations, and the role of pharmacists.

Pharmacists’ Role in Supporting Adherence and Proper Administration of Enlicitide

Pharmacists enhance LDL cholesterol management with tailored solutions like enlicitide, improving patient adherence and outcomes in cardiovascular care.

Enhancing Functional Assessment Through Objective Activity Monitoring

Discover how objective activity monitoring with accelerometers transforms cardiovascular risk assessment and treatment evaluation, enhancing patient care for pharmacists.

Optimizing Hypertension Management Through Early Combination Therapy

Expert highlights the benefits of early combination therapy in hypertension management, emphasizing improved blood pressure control and reduced side effects.

Lutetium-177 PSMA-617 Plus ADT and ARPI Improves Progression-Free Survival in PSMAddition Trial

New research highlights the benefits of combining lutetium PSMA 617 with standard treatments, showing improved outcomes for prostate cancer patients.

Advertisement
Advertisement

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy